Health tech startup PocDoc has raised £5 million in a pre-Series A funding round to expand its app-based platform, which offers end-to-end digital pathways for disease assessment, diagnosis, and treatment.
With this latest round, PocDoc has now raised over £10 million in pre-A funding. The recent £5 million investment comes from MMC Ventures, Molten VC, Simplyhealth Ventures, and a new investor, KHP Ventures—an NHS-backed fund focused on scaling health tech innovations across digital health and med tech.
The new funding will accelerate PocDoc’s growth, driven by expanding partnerships with pharmacies, retailers, and corporations, as well as deepening its ties with the NHS across the UK.
Steve Roest, PocDoc's CEO and cofounder, described the investment round as a “major endorsement” of the company's technology and progress. He emphasized that the involvement of KHP Ventures, backed by NHS institutions, reflects PocDoc’s alignment with NHS priorities and its impact on public health.
Roest highlighted PocDoc’s mission to revolutionize access to screening, enabling earlier detection and treatment of chronic diseases, ultimately reducing strain on healthcare services. He also mentioned upcoming tests for metabolic, kidney, and whole-body health, and plans for international expansion in 2025.
PocDoc’s platform leverages machine learning, data integration, and real-time alerting to provide patients with comprehensive health assessments, connect them with clinicians, and integrate results into patient records for seamless follow-up care.
Tim Irish, partner at KHP Ventures, noted PocDoc’s strong progress and expressed excitement about supporting the next phase of its growth.
In summer 2024, PocDoc introduced its ‘Healthy Heart Check’ feature, a point-of-care test for cardiovascular disease that provides instant results through the app. The service has already been used by tens of thousands of patients, with 97% of surveyed users recommending it to others.
Click here to read the original news story.